IL-22 R alpha 1

IL-22 R alpha 1 Overview

English NameInterleukin-22 receptorApproved Drugs0
Drugs in Clinical Trials5Target Synonym
Highest Development StagePhase 2 Clinical
English NameInterleukin-22 receptor
Target Synonym
Approved Drugs0
Drugs in Clinical Trials5
Highest Development StagePhase 2 Clinical

IL-22 R alpha 1 Product List

  • Product Category

    Protein (4)

  • Product Status

    Launched (4)

  • Species

    Human (2)Mouse (1)Cynomolgus (1)

  • Tag

    Fc Tag (1)His Tag (3)

  • Conjugate

    Unconjugated (4)

IL-22 R alpha 1 Background

Interleukin-22 receptor subunit alpha-1(IL22RA1) is a component of the receptor for IL20, IL22 and IL24.Component of IL22 receptor formed by IL22RA1 and IL10RB enabling IL22 signaling via JAK/STAT pathways. IL22 also induces activation of MAPK1/MAPK3 and Akt kinases pathways. Component of one of the receptor for IL20 and IL24 formed by IL22RA1 and IL20RB also signaling through STATs activation. Mediates IL24 antiangiogenic activity as well as IL24 inhibitory effect on endothelial cell tube formation and differentiation.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Efmarodocokin alfaRO-7021610; UTTR-1147A; RG-7880Phase 2 ClinicalGenentech IncDiabetic Foot; Coronavirus Disease 2019 (COVID-19); Graft vs Host Disease; Colitis, Ulcerative; Crohn Disease
Details
TemtokibartARGX-112; LEO-138559; LP-0145Phase 2 ClinicalArgenx Se, Leo Pharma IncDermatitis, Atopic
Details
CK-0045CK-0045Phase 2 ClinicalCytoki Pharma ApSDiabetes Mellitus, Type 2; Obesity; Overweight
Details
Eflepedocokin alfaF-652Phase 2 ClinicalEvive Biotech LtdHepatitis, Alcoholic; Pancreatitis; Coronavirus Disease 2019 (COVID-19); Graft vs Host Disease; Acute-On-Chronic Liver Failure
Details
ABBV-022ABBV-022Phase 1 ClinicalAbbvie IncColitis, Ulcerative
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland